Source: Annual Congress 2004 - Management and resistance in tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Karakurt, T. Morali, M. Yavsan, N. Gungor, B. Uskul, H. Turker (Istanbul, Turkey). The effect of anti-inflammatory treatment to the pleural thickening in tuberculosis pleuresy. Eur Respir J 2004; 24: Suppl. 48, 4422

Member's Comments

No comment yet.

Related content which might interest you: Comparison of the immunologic profile between pleural effusion and cavitary parenchymal disease in young patients with pulmonary tuberculosis Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009 Evaluation of inflammatory mediators of pleural effusion in tuberculosis and non-tuberculosis patients Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020 Survival on antifibrotic therapy in IPF – the impact of pleural plaques, concomitant emphysema and definite vs possible UIP Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004 Is residual pleural thickening and functional sequelae predictable in tuberculous pleurisy? Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006 Early effective drainage in the treatment of loculated tuberculous pleurisy Source: Eur Respir J 2008; 31: 1261-1267 Year: 2008 An anti-inflammatory effect of azithromycin in cystic fibrosis Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Original methods for prophylaxis and treatment of pleural empyema and bronchial fistulas after pneumonectomy with destructive tuberculosis of lungs and pleura Source: Eur Respir J 2003; 22: Suppl. 45, 323s Year: 2003 The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 Immune responses in the lungs of patients with tuberculous pleural effusion without parenchymal tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 Morphological evidence of anti-inflammatory effect of interferon-α at pulmonary TB patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 Response of pulmonary tuberculomas to anti-tuberculous treatment Source: Eur Respir J 2004; 23: 452-455 Year: 2004 Long-term use of inhaled corticoids on the development of pleural effusion in community-acquired pneumonia Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Pleural fluid AFB culture predicts the development of residual pleural thickening in tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Incidence and aetiology of eosinophilic pleural effusion Source: Eur Respir J 2009; 34: 1111-1117 Year: 2009 Comparison in effectiveness and proinflammatory mediators between talc, doxycycline and tetracycline for pleurodesis in malignant pleural effusions (MPE) Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy Year: 2006 The relation of the pleural thickening in tuberculosis pleurisy with the activity of adenosine deaminase Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004 The effect of IFN-gamma on disease severity in pericardial tuberculosis Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Predictors of residual pleural opacity in tuberculous pleurisy Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007 The effect of a pleural diseases clinic on pleural effusion admission rates Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012